Market Overview

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest ROE

Share:
Related VIVO
Benzinga's Daily Biotech Pulse: Sarepta's DMD Gene Therapy, Anika's Flunked Trial, Eidos To Commence Trading
Benzinga's Daily Biotech Pulse: Biohaven Sells Right To Drug, Obseva To Sell Shares
Related NEOG
Benzinga's Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid Addiction Drug
Benzinga's Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma's Q4 Miss, Sage Inks Deal With Japan's Shionogi

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on equity.

The trailing-twelve-month return on equity at Meridian Bioscience (NASDAQ: VIVO) is 22.58%. Meridian Bioscience's revenue for the same period is $171.20 million.

The trailing-twelve-month return on equity at Neogen (NASDAQ: NEOG) is 10.90%. Neogen's operating margin for the same period is 18.46%.

The trailing-twelve-month return on equity at Trinity Biotech plc (NASDAQ: TRIB) is 10.77%. Trinity Biotech's profit margin for the same period is 20.71%.

The trailing-twelve-month return on equity at Abaxis (NASDAQ: ABAX) is 8.20%. Abaxis' PEG ratio is 2.69.

Posted-In: Diagnostic Substances Industry highest ROE small-capTrading Ideas

 

Related Articles (ABAX + NEOG)

View Comments and Join the Discussion!